Monthly Archives: March 2017

http://www.lslog.com/sanofi-following-in-endos-footsteps-hands-back-rights-to-vivus-on-ed-med-stendra/Sanofi, following in Endo's footsteps, hands back rights to Vivus on ED med Stendra

Sanofi, following in Endo's footsteps, hands back rights to Vivus on ED med Stendra

Sanofi, following in Endo’s footsteps, hands back rights to Vivus on ED med Stendra Sanofi, following in Endo’s footsteps, hands back rights to Vivus on ED med Stendra chelfand Wed, […]

http://www.lslog.com/donald-trump-aims-for-1-2b-in-nih-cuts-this-year/Donald Trump aims for $1.2B in NIH cuts this year

Donald Trump aims for $1.2B in NIH cuts this year

Donald Trump aims for .2B in NIH cuts this year Donald Trump aims for $1.2B in NIH cuts this year badams Wed, 03/29/2017 – 04:24 Source: FierceMedicalDevices News Donald […]

http://www.lslog.com/pfizer-men-b-shot-trumenba-wins-eu-committees-backing/Pfizer Men B shot Trumenba wins EU committee's backing

Pfizer Men B shot Trumenba wins EU committee's backing

Pfizer Men B shot Trumenba wins EU committee’s backing Pfizer Men B shot Trumenba wins EU committee’s backing esagonowsky Tue, 03/28/2017 – 15:13 Source: Fierce Pharma Pfizer Men B […]

http://www.lslog.com/sanofi-regeneron-ready-to-roll-with-3b-plus-dupixent-approval/Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval

Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval

Sanofi, Regeneron ready to roll with B-plus Dupixent approval Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval tracy Tue, 03/28/2017 – 11:50 Source: Fierce Pharma Sanofi, Regeneron ready […]

http://www.lslog.com/bms-seeks-leg-up-in-immuno-oncology-with-parker-institute-and-cri-pact/BMS seeks leg up in immuno-oncology with Parker Institute and CRI pact

BMS seeks leg up in immuno-oncology with Parker Institute and CRI pact

BMS seeks leg up in immuno-oncology with Parker Institute and CRI pact BMS seeks leg up in immuno-oncology with Parker Institute and CRI pact phil Tue, 03/28/2017 – 09:08 […]

http://www.lslog.com/tesaro-puts-astrazeneca-on-notice-with-early-fda-nod-for-lynparza-rival-niraparib/Tesaro puts AstraZeneca on notice with early FDA nod for Lynparza rival niraparib

Tesaro puts AstraZeneca on notice with early FDA nod for Lynparza rival niraparib

Tesaro puts AstraZeneca on notice with early FDA nod for Lynparza rival niraparib Tesaro puts AstraZeneca on notice with early FDA nod for Lynparza rival niraparib tracy Mon, 03/27/2017 – […]

http://www.lslog.com/allergans-ceo-pay-plummets-by-80-without-big-ma-and-strong-financials/Allergan's CEO pay plummets by 80% without big M&A and strong financials

Allergan's CEO pay plummets by 80% without big M&A and strong financials

Allergan’s CEO pay plummets by 80% without big M&A and strong financials Allergan’s CEO pay plummets by 80% without big M&A and strong financials chelfand Mon, 03/27/2017 – 11:44 […]

http://www.lslog.com/liver-cancer-miss-adds-to-litany-of-trial-failures-for-arqules-tivantinib/Liver cancer miss adds to litany of trial failures for ArQule's tivantinib

Liver cancer miss adds to litany of trial failures for ArQule's tivantinib

Liver cancer miss adds to litany of trial failures for ArQule’s tivantinib Liver cancer miss adds to litany of trial failures for ArQule’s tivantinib phil Mon, 03/27/2017 – 09:04 […]

http://www.lslog.com/allergan-paratek-hit-late-stage-acne-goals-prep-for-sarecycline-nda/Allergan, Paratek hit late-stage acne goals, prep for sarecycline NDA

Allergan, Paratek hit late-stage acne goals, prep for sarecycline NDA

Allergan, Paratek hit late-stage acne goals, prep for sarecycline NDA Allergan, Paratek hit late-stage acne goals, prep for sarecycline NDA badams Mon, 03/27/2017 – 07:54 Source: FierceMedicalDevices News Allergan, […]

http://www.lslog.com/purdue-and-shionogis-new-constipation-approval-goes-up-against-az-valeant-rivals/Purdue and Shionogi's new constipation approval goes up against AZ, Valeant rivals

Purdue and Shionogi's new constipation approval goes up against AZ, Valeant rivals

Purdue and Shionogi’s new constipation approval goes up against AZ, Valeant rivals Purdue and Shionogi’s new constipation approval goes up against AZ, Valeant rivals chelfand Fri, 03/24/2017 – 11:05 […]